We are live on
!
Find out more
Mackenzie Financial Portfolio holdings
AUM
$100B
1-Year Est. Return
36.93%
This Fund
S&P 500
This Quarter
Est. Return
+15.99%
1 Year Est. Return
+36.93%
3 Year Est. Return
+93.95%
5 Year Est. Return
+113.13%
10 Year Est. Return
+336.84%
AUM
$100B
AUM Growth
+$16.6B
(+20%)
Cap. Flow
-$160M
Cap. Flow
% of AUM
-0.16%
Top 10 Holdings %
Top 10 Hldgs %
27.79%
Holding
1,710
New
290
Increased
784
Reduced
459
Closed
156
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Becton Dickinson
BDX
|
+$208M |
| 2 |
UnitedHealth
UNH
|
+$204M |
| 3 |
SLB Ltd
SLB
|
+$141M |
| 4 |
Amazon
AMZN
|
+$134M |
| 5 |
Gilead Sciences
GILD
|
+$134M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CME Group
CME
|
+$259M |
| 2 |
Apple
AAPL
|
+$216M |
| 3 |
ExxonMobil
XOM
|
+$214M |
| 4 |
Franco-Nevada
FNV
|
+$198M |
| 5 |
McKesson
MCK
|
+$195M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 24.67% |
| 2 | Technology | 18.8% |
| 3 | Energy | 9.82% |
| 4 | Industrials | 9.76% |
| 5 | Materials | 8.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1276
Eagle Materials
EXP
$5.97B
| $600K | ﹤0.01% |
2,668
+822
| +45% | +$172K |
|
|
TMQ
1277
Trilogy Metals
TMQ
$570M
| $595K | ﹤0.01% |
119,918
+10,568
| +10% | +$43.5K |
|
1278
Lazard
LAZ
$4.39B
| $594K | ﹤0.01% |
14,161
+2,054
| +17% | +$94K |
|
1279
Solventum
SOLV
$15.6B
| $593K | ﹤0.01% |
7,688
-34,779
| -82% | -$2.54M |
|
1280
Align Technology
ALGN
$11.3B
| $592K | ﹤0.01% |
3,511
-577,196
| -99% | -$100M |
|
1281
Alcon
ALC
$34.1B
| $591K | ﹤0.01% |
349,909
+6,429
| +2% | +$450K |
|
1282
Avista
AVA
$3.14B
| $589K | ﹤0.01% |
14,406
-7,310
| -34% | -$301K |
|
1283
Caesars Entertainment
CZR
$6.05B
| $589K | ﹤0.01% |
19,506
+5,707
| +41% | +$161K |
|
1284
Medallion Financial
MFIN
$281M
| $588K | ﹤0.01% |
+57,574
| New | +$545K |
|
1285
Boyd Gaming
BYD
$5.67B
| $586K | ﹤0.01% |
6,630
+1,183
| +22% | +$101K |
|
1286
WillScot Mobile Mini Holdings
WSC
$3.62B
| $582K | ﹤0.01% |
+20,171
| New | +$488K |
|
1287
Schneider National
SNDR
$6.14B
| $580K | ﹤0.01% |
15,866
+196
| +1% | +$6.39K |
|
1288
UFP Industries
UFPI
$4.65B
| $579K | ﹤0.01% |
6,385
+1,808
| +40% | +$157K |
|
1289
UiPath
PATH
$7.87B
| $578K | ﹤0.01% |
53,188
-36,202
| -40% | -$386K |
|
1290
Axsome Therapeutics
AXSM
$10.8B
| $574K | ﹤0.01% |
+2,347
| New | +$509K |
|
1291
Golub Capital BDC
GBDC
$3.38B
| $572K | ﹤0.01% |
44,394
+205
| +0.5% | +$2.67K |
|
1292
Amplify Energy
AMPY
$203M
| $567K | ﹤0.01% |
+142,552
| New | +$732K |
|
1293
Outfront Media
OUT
$5.1B
| $567K | ﹤0.01% |
+17,309
| New | +$537K |
|
1294
IDEX
IEX
$16.5B
| $567K | ﹤0.01% |
2,498
-147
| -6% | -$31.1K |
|
1295
RBB Bancorp
RBB
$458M
| $563K | ﹤0.01% |
+20,546
| New | +$493K |
|
|
PAYP
1296
PayPay
PAYP
$11.5B
| $561K | ﹤0.01% |
+39,160
| New | +$720K |
|
1297
Blue Owl Capital
OBDC
$5.62B
| $561K | ﹤0.01% |
51,583
+1,437
| +3% | +$16.1K |
|
|
UROY
1298
Uranium Royalty Corp
UROY
$1.69B
| $552K | ﹤0.01% |
139,981
+19,567
| +16% | +$68.6K |
|
|
MRX
1299
Marex Group Limited Ordinary Shares
MRX
$5.63B
| $546K | ﹤0.01% |
9,269
-96,707
| -91% | -$5.32M |
|
1300
McCormick & Company Non-Voting
MKC
$14B
| $539K | ﹤0.01% |
10,698
-164,911
| -94% | -$8.09M |
|
Similar funds
AI
Mackenzie Financial's Q2 2026 Portfolio in Review
As of Q2 2026, Mackenzie Financial held 1,710 positions worth $100B, up 20% from $83.3B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Mackenzie Financial's Q2 2026 filing shows 290 new, 784 increased, 459 reduced and 156 closed positions. Its largest new stake was OceanaGold Corp: 3,205,562 shares worth $114M. The largest sale was CME Group, an estimated $259M.
By sector, the portfolio is most concentrated in Financials at 25% of assets, up from 20% a quarter earlier, followed by Technology and Energy.
- Mackenzie Financial's largest Q2 2026 buy was OceanaGold Corp: 3,205,562 shares worth $114M.
- Mackenzie Financial added most to Becton Dickinson in Q2 2026, an estimated $208M increase.
- Mackenzie Financial's biggest Q2 2026 reduction was CME Group, cutting an estimated $259M.
- Mackenzie Financial fully exited HealthEquity in Q2 2026, selling an estimated $107M.
- Mackenzie Financial's ten largest holdings make up 28% of its $100B portfolio in Q2 2026.
- Mackenzie Financial opened 290 new positions and closed 156 in Q2 2026.
- Mackenzie Financial's portfolio value rose 20% quarter-over-quarter to $100B.
Based on Mackenzie Financial's 13F filing for Q2 2026, filed 13 Aug 2026.